Researchers have developed a nanoparticle-based drug delivery method that, in early testing, rapidly reduced endometriosis. The condition is chronic and incurable, affecting roughly one in ten women. The targeted nanotherapy works by delivering medication directly to affected tissue, which may improve treatment efficacy while limiting side effects.
The team behind the work says the results lay groundwork for a potential new therapy. Because the findings come from early testing, further research will be needed to confirm safety and effectiveness in humans. Still, the approach represents a step toward addressing a significant unmet medical need.